The Readout Loud

212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy


Listen Later

When is data "practice-changing"? How many Covid-19 vaccines do we need? And what does it mean when the FDA asks for more time? With the world's largest cancer conference just concluded, we explain the most important data presented at the meeting, including a blockbuster clinical trial that promises to change the treatment of advanced breast cancer. We also discuss an FDA controversy in the making, a pair of new Covid-19 vaccines, and the frustrating process of finding new treatments for depression.
...more
View all episodesView all episodes
Download on the App Store

The Readout LoudBy STAT

  • 4.5
  • 4.5
  • 4.5
  • 4.5
  • 4.5

4.5

309 ratings


More shows like The Readout Loud

View all
Planet Money by NPR

Planet Money

30,667 Listeners

Odd Lots by Bloomberg

Odd Lots

1,896 Listeners

What the Health? From KFF Health News by KFF Health News

What the Health? From KFF Health News

499 Listeners

The Indicator from Planet Money by NPR

The Indicator from Planet Money

9,529 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

6,072 Listeners

Tradeoffs by Tradeoffs

Tradeoffs

395 Listeners

Biotech 2050 Podcast by Biotech 2050

Biotech 2050 Podcast

61 Listeners

Business Of Biotech by Ben Comer

Business Of Biotech

86 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

34 Listeners

Dwarkesh Podcast by Dwarkesh Patel

Dwarkesh Podcast

505 Listeners

Hard Fork by The New York Times

Hard Fork

5,472 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

19 Listeners

Ground Truths by Eric Topol

Ground Truths

48 Listeners

Money Stuff: The Podcast by Bloomberg

Money Stuff: The Podcast

388 Listeners

The BioCentury Show by BioCentury

The BioCentury Show

12 Listeners